Robert Zerbe Net Worth (2024) | wallmine
By Isabella Wilson
Robert Zerbe biography
Dr. Robert L. Zerbe, M.D., is an Independent Chairman of the Board of the company. Dr. Zerbe is a director since January 2006 and the Chairman of our Board of Directors since October 2012, was, until July 2016, the Chief Executive Officer of QUATRx Pharmaceuticals Company, a venture-backed drug development company which he co-founded in 2000. Prior to his role at QUATRx, Dr. Zerbe held several senior executive management positions with major pharmaceutical companies including Eli Lilly and Company (from 1982 to 1993) and Pfizer (formerly Parke-Davis) (from 1993 to 2000). During his tenure at Eli Lilly, Dr. Zerbe's clinical research and development positions included Managing Director, Lilly Research Center U.K., and Vice President of Clinical Investigation and Regulatory Affairs. He joined Parke-Davis in 1993, becoming Senior Vice President of Worldwide Clinical Research and Development. In this capacity he led the clinical development programs for a number of key products, including Lipitor® and Neurontin®. Dr. Zerbe received his M.D. from the Indiana University School of Medicine, and has completed post-doctoral work in internal medicine, endocrinology and neuroendocrinology at Indiana University and the National Institutes of Health. He also serves on the board of directors of Metabolic Solutions Development Company and Cirius Therapeutics, both private companies focusing on metabolic diseases.
What is the salary of Robert Zerbe?
As the Independent Chairman of the Board of Vericel Corp, the total compensation of Robert Zerbe at Vericel Corp is $253,085. There are 7 executives at Vericel Corp getting paid more, with Dominick Colangelo having the highest compensation of $5,385,530.
